Jefferies raised the firm’s price target on IBM (IBM) to $270 from $245 and keeps a Hold rating on the shares. Software revenue accelerated for the fourth straight quarter to 11% year-over-year constant currency growth and IBM’s GenAI book of business accelerated, the analyst tells investors in a post-earnings note. The calendar 2025 outlook “was positive as well,” with revenue growth expected to accel to greater than 5% year-over-year in constant currency from 3% in 2024, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM: